ATE387426T1 - Verfahren zur herstellung von shogaol und zwischenprodukte für dessen synthese - Google Patents
Verfahren zur herstellung von shogaol und zwischenprodukte für dessen syntheseInfo
- Publication number
- ATE387426T1 ATE387426T1 AT03723212T AT03723212T ATE387426T1 AT E387426 T1 ATE387426 T1 AT E387426T1 AT 03723212 T AT03723212 T AT 03723212T AT 03723212 T AT03723212 T AT 03723212T AT E387426 T1 ATE387426 T1 AT E387426T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- shogaols
- producing
- intermediates
- carbon atoms
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 title 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 239000000543 intermediate Substances 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 229940127557 pharmaceutical product Drugs 0.000 abstract 2
- 241000234314 Zingiber Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/512—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being a free hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
- C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002137721A JP3951798B2 (ja) | 2002-05-13 | 2002-05-13 | ショウガオール類の製造方法および合成用中間体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE387426T1 true ATE387426T1 (de) | 2008-03-15 |
Family
ID=29416820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03723212T ATE387426T1 (de) | 2002-05-13 | 2003-04-25 | Verfahren zur herstellung von shogaol und zwischenprodukte für dessen synthese |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7049455B2 (de) |
| EP (1) | EP1506958B1 (de) |
| JP (1) | JP3951798B2 (de) |
| AT (1) | ATE387426T1 (de) |
| DE (1) | DE60319367D1 (de) |
| WO (1) | WO2003095424A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006073042A1 (ja) * | 2005-01-05 | 2006-07-13 | Toagosei Co., Ltd. | Ｎｒｆ２依存遺伝子の活性化剤 |
| JP5103296B2 (ja) * | 2008-06-23 | 2012-12-19 | 花王株式会社 | ジンジャーオレオレジン精製物の製造方法 |
| CN102215857B (zh) * | 2008-11-19 | 2015-06-17 | 庆熙大学校产学协力团 | 包含生姜提取物或姜烯酚的药物组合物 |
| JP5758580B2 (ja) * | 2010-03-04 | 2015-08-05 | ポーラ化成工業株式会社 | プロトンポンプ阻害剤 |
| US11007058B2 (en) | 2013-03-15 | 2021-05-18 | Edwards Lifesciences Corporation | Valved aortic conduits |
| US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
| USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1510511A4 (de) * | 2002-05-27 | 2005-12-28 | Toagosei Co Ltd | Gingerolanaloga und deren anwendung |
-
2002
- 2002-05-13 JP JP2002137721A patent/JP3951798B2/ja not_active Expired - Fee Related
-
2003
- 2003-04-25 AT AT03723212T patent/ATE387426T1/de not_active IP Right Cessation
- 2003-04-25 EP EP03723212A patent/EP1506958B1/de not_active Expired - Lifetime
- 2003-04-25 DE DE60319367T patent/DE60319367D1/de not_active Expired - Lifetime
- 2003-04-25 WO PCT/JP2003/005377 patent/WO2003095424A1/ja not_active Ceased
- 2003-04-25 US US10/514,130 patent/US7049455B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7049455B2 (en) | 2006-05-23 |
| US20050159611A1 (en) | 2005-07-21 |
| EP1506958A1 (de) | 2005-02-16 |
| EP1506958B1 (de) | 2008-02-27 |
| EP1506958A4 (de) | 2006-05-31 |
| DE60319367D1 (de) | 2008-04-10 |
| WO2003095424A1 (en) | 2003-11-20 |
| JP2003327574A (ja) | 2003-11-19 |
| JP3951798B2 (ja) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0313612D0 (en) | Organic compounds | |
| ATE527228T1 (de) | Verfahren zur herstellung von beta-santalol und derivaten davon | |
| DE60319367D1 (de) | Verfahren zur herstellung von shogaol und zwischenprodukte für dessen synthese | |
| ATE521600T1 (de) | Verfahren zur herstellung von statinen | |
| DE69832202D1 (de) | Zwischenprodukt und verfahren zur teilsynthese von paclitaxel und dessen analogen | |
| ATE273263T1 (de) | Verfahren zur kontinuierlichen herstellung von glutaraldehyd | |
| GB0015771D0 (en) | Cyclic ketones and their use in the synthesis of amino acids | |
| ATE489367T1 (de) | Verfahren und zwischenprodukt zur herstellung von donezepil | |
| WO2001000652A3 (de) | 11β-LANGKETTIG-SUBSTITUIERTE ESTRATRIENE, VERFAHREN ZUR HERSTELLUNG, PHARMAZEUTISCHE PRÄPARATE, DIE DIESE 11β-LANGKETTIG-SUBSTITUIERTEN ESTRATRIENE ENTHALTEN, SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN | |
| DE60015177D1 (de) | Verfahren zur herstellung von 2-[4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxyessigsäure und zwischenprodukte dafür | |
| DE60112241D1 (de) | Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen | |
| ATE234820T1 (de) | Aminoalkyloxime, verfahren zur dessen herstellung,ihre verwendung als medikamente und zwischenprodukte | |
| ATE255122T1 (de) | Verfahren zur herstellung von indolopyrrolocarbazol-derivaten, deren zwischenprodukte sowie verfahren zur herstellung der zwischenprodukte | |
| ATE425972T1 (de) | Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte | |
| MY107827A (en) | Isoquinolline compounds, compositions and use | |
| MY149357A (en) | Purification process | |
| ATE473213T1 (de) | Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
| ATE236109T1 (de) | Verfahren zur herstellung von 1,5-pentandiol- derivaten | |
| WO2003004515A1 (en) | Process for production of estradiol derivatives, intermediates used in the process and process for production thereof | |
| DE50205442D1 (de) | Verfahren zur herstellung optisch aktiver dihydropyrone | |
| ATE402918T1 (de) | Verfahren zur herstellung eines iminzwischenprodukts | |
| DE602005004278D1 (de) | Arylpyrrol mit antitubulinwirkung, arylfulran- und arylthiopenderivate, verfahren zur herstellung und verwendung als antimitotikum | |
| DK1163257T3 (da) | Fremgangsmåde til fremstilling af 4,4-dimethyl-3beta-hydroxypregna-8,14-dien-21-carboxylsyreestere og mellemprodukter i fremgangsmåden | |
| ATE479649T1 (de) | Zwischenprodukte und verfahren zur herstellung aromatischer derivate von 1-adamantan | |
| DE59907019D1 (de) | Verfahren zur herstellung von 4,4-dimethyl-5 alpha-cholesta-8,14,24-trien-3 beta-ol und zwischenprodukte im verfahren (i) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |